| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AWH | Common Stock | Options Exercise | $0 | +20,000 | $0.000000 | 20,000 | 31 Dec 2024 | Direct | F1 | |
| transaction | AWH | Common Stock | Tax liability | $4,449 | -6,356 | -32% | $0.7000 | 13,644 | 08 Jan 2025 | Direct | F2, F5 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AWH | Restricted Stock Units | Options Exercise | $0 | +20,000 | $0.000000 | 0 | 31 Dec 2024 | Common Stock | 20,000 | Direct | F3, F4 |
| Id | Content |
|---|---|
| F1 | Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On October 28, 2024, the reporting person was granted 20,000 RSUs, which vested on December 31, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on October 28, 2024. |
| F2 | This line reflects the tax withholding on the vesting of RSUs that vested on December 31, 2024. |
| F3 | Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock. |
| F4 | On October 28, 2024, the reporting person was granted 20,000 RSUs, which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4. |
| F5 | This report is being filed to correct the number of shares held after tax withholding on the vesting of RSUs that vested on December 31, 2024. |